EU CHMP recommends approval of Merck’s Keytruda plus Padcev as perioperative treatment for adults with cisplatin-ineligible resectable muscle-invasive bladder cancer: Rahway, Ne ...

The NHS is rolling out a one-minute immunotherapy injection for over a dozen types of cancer, including lung, breast, and cervical cancer. This new injectable form of pembrolizumab (Keytruda) can ...

Exelixis, Inc. (Nasdaq: EXEL) today announced that the company has entered into a clinical development collaboration with Merck, known as MSD outside of the United States and Canada, to supply ...

Health minister hopes a key injectable cancer drug will be available in all five trusts "as soon as possible".

The Department of Health (DoH) said it is "aware" of the jab and is "exploring" how it can be made available to patients in Northern Ireland "as soon as possible".

New NHS pembrolizumab immunotherapy injection has been praised by Dr Hilary Jones ...

Shirley Xerxes was one of the first in the UK to receive the injectable form of Keytruda on the NHS A new injectable form of a key cancer drug could see thousands of NHS patients across the UK ...

The treatment, now being offered at Royal Cornwall Hospitals NHS Trust (RCHT), is an injectable form of pembrolizumab (Keytruda).

The NHS is introducing a one-minute jab that could help tens of thousands of cancer patients.

Patients in East Yorkshire and North Lincolnshire are set to benefit from quicker treatment.

NHS rolls out “one minute” immunotherapy jab NHS England announced that it was rolling out a new injectable form of the ...

Dr Hilary Jones has praised a new NHS injection that not only takes 60 seconds to administer but is also set to help tens of ...